Financial News · Live Terminal

Page 144 of 156

Remitly Global Insider Sold Shares Worth $801,600, According to a Recent SEC Filing

Phillip John Riese, Director, on April 17, 2026, sold 40,000 shares in Remitly Global (RELY) for $801,600. Following the Form 4 filing with the SEC, Riese has control over a total of 122,496 common shares of the company, with 122,496 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1782170/000178217026000035/xslF345X05/wk-form4_1776803221.xml

$RELY

Insider Trading109d ago

Hershey Insider Sold Shares Worth $291,150, According to a Recent SEC Filing

Steven E Voskuil, Senior Vice President, Chief Financial Officer, on April 20, 2026, sold 1,500 shares in Hershey (HSY) for $291,150. Following the Form 4 filing with the SEC, Voskuil has control over a total of 57,695 common shares of the company, with 57,695 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/47111/000004711126000175/xslF345X05/form4.xml

$HSY

Insider Trading109d ago

Travelers Companies Insider Sold Shares Worth $869,980, According to a Recent SEC Filing

Diane Kurtzman, Executive Vice President & Chief Human Resources Officer, on April 20, 2026, sold 2,867 shares in Travelers Companies (TRV) for $869,980. Following the Form 4 filing with the SEC, Kurtzman has control over a total of 5,298 common shares of the company, with 5,298 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/86312/000008631226000117/xslF345X05/form4.xml

$TRV

Insider Trading109d ago

Novanta Insider Sold Shares Worth $845,325, According to a Recent SEC Filing

Matthijs Glastra, Director, Chief Executive Officer, on April 17, 2026, sold 6,500 shares in Novanta (NOVT) for $845,325. Following the Form 4 filing with the SEC, Glastra has control over a total of 111,143 common shares of the company, with 56,761 shares held directly and 54,382 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1076930/000107693026000076/xslF345X05/form4.xml

$NOVT

Insider Trading109d ago

Equitable Holdings Insider Sold Shares Worth $1,652,640, According to a Recent SEC Filing

Mark Pearson, Director, President and CEO, on April 20, 2026, sold 39,700 shares in Equitable Holdings (EQH) for $1,652,640. Following the Form 4 filing with the SEC, Pearson has control over a total of 789,183 common shares of the company, with 789,183 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1333986/000162828026026292/xslF345X05/wk-form4_1776802726.xml

$EQH

Insider Trading109d ago

Travelers Companies Insider Sold Shares Worth $1,956,549, According to a Recent SEC Filing

Jeffrey P. Klenk, Executive Vice President and President, Bond & Specialty Insurance, on April 20, 2026, sold 6,414 shares in Travelers Companies (TRV) for $1,956,549. Following the Form 4 filing with the SEC, Klenk has control over a total of 6,075 common shares of the company, with 6,075 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/86312/000008631226000113/xslF345X05/form4.xml

$TRV

Insider Trading109d ago

Arteris Insider Sold Shares Worth $1,994,354, According to a Recent SEC Filing

Saiyed Atiq Raza, Director, on April 17, 2026, sold 90,000 shares in Arteris (AIP) for $1,994,354. Following the Form 4 filing with the SEC, Raza has control over a total of 320,839 common shares of the company, with 20,839 shares held directly and 300,000 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1667011/000118456326000003/xslF345X05/primarydocument.xml

$AIP

Insider Trading109d ago

Arteris Insider Sold Shares Worth $442,168, According to a Recent SEC Filing

Antonio J Viana, Director, on April 17, 2026, sold 20,000 shares in Arteris (AIP) for $442,168. Following the Form 4 filing with the SEC, Viana has control over a total of 165,460 common shares of the company, with 20,840 shares held directly and 144,620 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1667011/000188868626000001/xslF345X05/primarydocument.xml

$AIP

Insider Trading109d ago

Incyte Insider Sold Shares Worth $1,801,366, According to a Recent SEC Filing

Pablo J Cagnoni, President, Global Head of R&D, on April 17, 2026, sold 18,667 shares in Incyte (INCY) for $1,801,366. Following the Form 4 filing with the SEC, Cagnoni has control over a total of 262,692 common shares of the company, with 262,692 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/879169/000120570326000012/xslF345X05/wk-form4_1776802145.xml

$INCY

Insider Trading109d ago

Goldman Sachs Group Insider Sold Shares Worth $1,024,895, According to a Recent SEC Filing

Alex S Golten, Chief Risk Officer, on April 17, 2026, sold 1,115 shares in Goldman Sachs Group (GS) for $1,024,895. Following the Form 4 filing with the SEC, Golten has control over a total of 3,694 common shares of the company, with 3,694 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/886982/000205084926000012/xslF345X05/wk-form4_1776801830.xml

$GS

Insider Trading109d ago

Credit Acceptance Insider Sold Shares Worth $1,576,894, According to a Recent SEC Filing

Jay D Martin, Chief Financial Officer, on April 17, 2026, sold 3,000 shares in Credit Acceptance (CACC) for $1,576,894. Following the Form 4 filing with the SEC, Martin has control over a total of 25,963 common shares of the company, with 25,963 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/885550/000088555026000060/xslF345X05/wk-form4_1776801859.xml

$CACC

Insider Trading109d ago

Badger Meter Insider Bought Shares Worth $258,573, According to a Recent SEC Filing

Kenneth Bockhorst, Director, Chairman, President & CEO, on April 21, 2026, executed a purchase for 2,200 shares in Badger Meter (BMI) for $258,573. Following the Form 4 filing with the SEC, Bockhorst has control over a total of 51,676 common shares of the company, with 51,676 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/9092/000119312526166603/xslF345X05/ownership.xmlPrice: $119.35, Change: $+5.94, Percent Change: +5.23%

$BMI

Insider Trading109d ago

Davey Tree Expert Insider Sold Shares Worth $740,122, According to a Recent SEC Filing

Joseph R Paul, Director, Executive Vice President & CFO, on April 17, 2026, sold 26,816 shares in Davey Tree Expert (NONE) for $740,122. Following the Form 4 filing with the SEC, Paul has control over a total of 363,585 common shares of the company, with 339,413 shares held directly and 24,172 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/277638/000162828026026162/xslF345X05/wk-form4_1776787307.xml

$NONE

Insider Trading109d ago

Pagseguro Digital Insider Sold Shares Worth $2,252,000, According to a Recent SEC Filing

Alexandre Magnani, Director, on April 17, 2026, sold 200,000 shares in Pagseguro Digital (PAGS) for $2,252,000. Following the Form 4 filing with the SEC, Magnani has control over a total of 607,390 Class A common shares of the company, with 607,390 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1712807/000129281426002435/xslF345X05/ownership.xmlPrice: $11.31, Change: $-0.01, Percent Change: -0.09%

$PAGS

Insider Trading109d ago

Darden Restaurants Insider Sold Shares Worth $731,837, According to a Recent SEC Filing

Douglas J. Milanes, Senior Vice President, Chief Supply Chain Officer, on April 17, 2026, sold 3,620 shares in Darden Restaurants (DRI) for $731,837. Following the Form 4 filing with the SEC, Milanes has control over a total of 274 common shares of the company, with 274 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/940944/000122520826004575/xslF345X05/doc4.xmlPrice: $197.49, Change: $-4.36, Percent Change: -2.16%

$DRI

Insider Trading109d ago

Marvell Technology Insider Sold Shares Worth $1,355,000, According to a Recent SEC Filing

Mark Casper, Executive Vice President & Chief Legal Officer, on April 17, 2026, sold 10,000 shares in Marvell Technology (MRVL) for $1,355,000. Following the Form 4 filing with the SEC, Casper has control over a total of 46,141 common shares of the company, with 35,878 shares held directly and 10,263 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1835632/000162828026026152/xslF345X05/wk-form4_1776784235.xmlPrice: $151.25, Change: $+3.41, Percent Change: +2.30%

$MRVL

Insider Trading109d ago

United Therapeutics Insider Sold Shares Worth $5,778,607, According to a Recent SEC Filing

James Edgemond, CFO and Treasurer, on April 20, 2026, sold 10,000 shares in United Therapeutics (UTHR) for $5,778,607. Following the Form 4 filing with the SEC, Edgemond has control over a total of 18,876 common shares of the company, with 18,876 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1082554/000163617826000011/xslF345X05/primarydocument.xmlPrice: $566.26, Change: $-7.19, Percent Change: -1.25%

$UTHR

Insider Trading109d ago

United Therapeutics Insider Sold Shares Worth $5,489,424, According to a Recent SEC Filing

Martine A Rothblatt, Director, Chairperson & CEO, on April 20, 2026, sold 9,500 shares in United Therapeutics (UTHR) for $5,489,424. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 679,797 common shares of the company, with 40,513 shares held directly and 639,284 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1082554/000110657826000036/xslF345X05/primarydocument.xmlPrice: $565.14, Change: $-8.30, Percent Change: -1.45%

$UTHR

Insider Trading110d ago

Kailera Therapeutics Insider Bought Shares Worth $134,375,008, According to a Recent SEC Filing

Andrew T. Kaplan, 10% Owner, Director, on April 16, 2026, executed a purchase for 8,398,438 shares in Kailera Therapeutics (KLRA) for $134,375,008. Following the Form 4 filing with the SEC, Kaplan has control over a total of 26,255,581 common shares of the company, with 26,255,581 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/2096997/000119312526164388/xslF345X05/ownership.xml

$KLRA

Insider Trading110d ago

Kailera Therapeutics Insider Bought Shares Worth $25,000,000, According to a Recent SEC Filing

Adam Koppel, 10% Owner, Director, on April 16, 2026, executed a purchase for 1,562,500 shares in Kailera Therapeutics (KLRA) for $25,000,000. Following the Form 4 filing with the SEC, Koppel has control over a total of 22,583,268 common shares of the company, with 22,583,268 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/2096997/000119312526164407/xslF345X05/ownership.xml

$KLRA

Showing 2861-2880 of 3112